Initial results of a dose escalation study of a selective and structurally differentiated PI3Kδ inhibitor, ME-401, in relapsed/refractory (R/R) follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) Meeting Abstract


Authors: Soumerai, J. D.; Pagel, J. M.; Jagadeesh, D.; Salman, H. S.; Kenkre, V. P.; Asch, A. S.; Stathis, A.; Reddy, N. M.; Iasonos, A.; Ghalie, R.; Zelenetz, A. D.
Abstract Title: Initial results of a dose escalation study of a selective and structurally differentiated PI3Kδ inhibitor, ME-401, in relapsed/refractory (R/R) follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)
Meeting Title: 54th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 15 Suppl.
Meeting Dates: 2018 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-05-20
Start Page: 404s
Language: English
ACCESSION: WOS:000442916002589
DOI: 10.1200/JCO.2018.36.15_suppl.7519
PROVIDER: wos
Notes: Meeting Abstract: 7519 -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Alexia Elia Iasonos
    319 Iasonos
  2. Andrew D Zelenetz
    736 Zelenetz